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ABSTRACT: The reactivation of the innate immune system by toll-like
receptor (TLR) agonists holds promise for anticancer immunotherapy.
Severe side effects caused by unspecific and systemic activation of the
immune system upon intravenous injection prevent the use of small-
molecule TLR agonists for such purposes. However, a covalent attachment
of small-molecule imidazoquinoline (IMDQ) TLR7/8 agonists to pH-
degradable polymeric nanogels could be shown to drastically reduce the
systemic inflammation but retain the activity to tumoral tissues and their
draining lymph nodes. Here, we introduce the synthesis of poly-
(norbornene)-based, acid-degradable nanogels for the covalent ligation of
IMDQs. While the intact nanogels trigger sufficient TLR7/8 receptor
stimulation, their degraded version of soluble, IMDQ-conjugated poly(norbornene) chains hardly activates TLR7/8. This renders
their clinical safety profile, as degradation products are obtained, which would not only circumvent nanoparticle accumulation in the
body but also provide nonactive, polymer-bound IMDQ species. Their immunologically silent behavior guarantees both spatial and
temporal control over immune activity and, thus, holds promise for improved clinical applications.
■ INTRODUCTION
The maturation of dendritic cells (DCs) to antigen-presenting
cells, the subsequent development of a T-cell-dependent
immune reaction, and the secretion of various chemokines
are of key interest in cancer immunotherapy.1 However, these
mechanisms are often disabled in tumoral tissues.2 On the
contrary, immature DCs suppress the activity of self-reactive,
anticancer T-cells and support the proliferation of immuno-
suppressive T-cells.3,4 Therefore, strong activators of the innate
immune system in the tumor microenvironment could
enhance DC maturation, lead to the depletion of anti-
inflammatory signals, induce the proliferation of antitumoral
T-cells, and turn immunologically “cold” tumors into “hot”.5
A strategy to increase the DC maturation and antigen
presentation to T-cells includes the activation of toll-like
receptors (TLR).6 These receptors normally recognize
pathogen-associated molecular patterns (PAMPs) like lip-
opolysaccharides, double- or single-stranded RNA, etc. Their
activation leads to the differentiation of immature DCs and the
stimulation of an active immune response.7 Among others,
potent TLR agonists like the TLR-7/8 agonist imidazoquino-
line (IMDQ) are under investigation as adjuvants in
vaccination8 as well as for their use in anticancer
immunotherapy.9
Unfortunately, the administration of the immunostimulant
IMDQ leads to a systemic activation of the immune system
due to the unfavorable pharmacokinetic profile of the small-
molecule drug.10−12 This may even trigger life-threatening
inflammatory cascade reactions, e.g., cytokine storms.13
Alternatively, the conjugation of a small-molecule IMDQ to
a nanoparticulate carrier was shown by others and us to
improve the pharmacokinetic parameters and constrain the
immune activity to the site of interest.14−20
The covalent attachment of IMDQ to a poly-
(methacrylamide)-based nanogel carrier was shown to result
in a more defined pharmacological profile in terms of spatial
control upon peritumoral injection and accumulation in the
draining lymph nodes.11,12,21,22 For that purpose, active-ester-
containing amphiphilic poly(methacrylate) block copolymers
were self-assembled into polymer micelles, covalently con-
jugated with IMDQ, and then cross-linked to yield drug-loaded
polymeric nanogels.12,14
Moreover, to prevent unfavorable nanotoxicities based on
carrier accumulation in the body, nanogels were reversibly
cross-linked with a pH-degradable ketal cross-linker that upon
exposure to endosomal acidic environments afforded unimeric
single-chain polymers that could be secreted renally.23,24
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Interestingly, for the degraded nanogels or polymer chains,
lymph node accumulation was significantly reduced; however,
in in vitro cell studies, the immune stimulatory activity
remained as high as for the intact nanogels.21 In principle, a
possible systemic inflammatory risk for the degraded polymer
chains bearing IMDQ groups could therefore not be excluded.
Thus, alternative strategies to omit the immune stimulation of
the degraded particle or soluble single-chain polymers would
be favorable to avoid unwanted side effects and result in not
only spatial but also temporal control over the IMDQ activity.
For that purpose, we were interested in altering the design of
IMDQ nanogel carrier systems that potentially meet these
criteria. For a convenient block copolymer fabrication of well-
defined polymers, the ring-opening metathesis polymerization
(ROMP) reaction was chosen. In comparison to controlled
radical polymerizations, ROMP enables a fast and effective
one-pot block copolymerization within short reaction
times.25−27 Especially, the use of the fast initiating ruthenium
metathesis catalyst (Grubbs third-generation catalyst) facili-
tates the production of low-polydispersity homo and
amphiphilic block copolymers.25
In analogy to the previously investigated poly-
(methacrylamide) nanogels,22,28,29 synthetic access to poly-
(norbornene)-based nanogels can be provided by copolymer-
izing mPEG and pentafluorophenyl esters containing norbor-
nenes. The mPEG side chains in the solvophilic block should
provide sufficient hydrophilicity and stealthlike shielding effect.
The solvophobic block composed of pentafluorophenyl esters
triggers phase separation and self-assembly into micelles in
polar aprotic solvents like dimethyl sulfoxide (DMSO).28 The
reactivity of pentafluorophenyl esters to primary amines30
guarantees a sequential covalent core modification with amine-
modified IMDQs,31 cross-linking with ketal bisamines, as well
as conversion with hydrophilic amines, altogether affording
pH-degradable nanogels, equipped with TLR7/8 agonists
(Figure 1).
Interestingly, in this study, we observed that in contrast to
ether- or ketal-cross-linked poly(norbornene)-based nanogels,
the non-cross-linked hydrophilic block polymers covalently
equipped with IMDQ did not stimulate the TLR-7/8. As they
are also obtained upon intracellular degradation of the ketal-
cross-linked nanogels, TLR7/8 immune stimulation is
switched off upon particle degradation, thus making these
systems highly attractive for spatial and temporal control over a
precise IMDQ immune stimulation.
■ MATERIALS AND METHODS
Instrumentation. All 1H nuclear magnetic resonance (NMR)
spectra were recorded at room temperature on a Bruker 300 MHz or
a 600 MHz FT NMR spectrometer (Bruker Avance III HD 300,
Bruker Avance II 400, Bruker Avance III 600). Chemical shifts are
provided in parts per million related to TMS. NMR spectra were
processed with MestReNova 11.0.4 by Mestrelab Research. Samples
were prepared in respective deuterated solvents, and their signals were
referenced to the residual nondeuterated solvent signal. Diffusion
ordered spectroscopy DOSY spectra were recorded at room
temperature on a Bruker 400 MHz FT NMR spectrometer (Bruker
Avance III HD 400) and processed by Bayesian DOSY transformation
(minimum, 1.00 × 10−8; maximum, 1.00 × 10−8; resolution factor,
1.00; repetition factor, 1; points in dimension, 64).
Dynamic light scattering (DLS) experiments were performed on a
Zetasizer Nano ZS (Malvern Instruments Ltd., Malvern, U.K.)
equipped with a HeNe laser (λ = 633 nm) and detected at a scattering
angle of 173° at 25 °C. The obtained data were processed by
cumulant fitting for z-average and polydispersity index (PDI) as well
as by CONTIN fitting for particle size distributions. Unless otherwise
stated, dust was removed from the sample prior to each measurement
by filtration through a GHP syringe filter (0.45 μm pore size,
Acrodisc). Kinetic measurements of nanogel stability (in phosphate-
buffered saline (PBS) pH 7.4) or degradation (in 100 mM acetate
buffer, pH 5.0, prepared from a 1:1 mixture of 100 mM sodium
acetate and 100 mM acetic acid) were recorded at time intervals of 5
min.
Size exclusion chromatography (SEC) characterization was
conducted in hexafluoroisopropanol (HFIP) (containing 3.0 g/L of
potassium trifluoroacetate) as eluent. The instrument was equipped
with a PU 2080+ pump, an autosampler AS1555, and an RI detector
RI2080+ from JASCO. Columns packed with modified silica were
obtained from MZ-Analysentechnik: PFG columns; particle size, 7
Figure 1. Synthetic concept for the fabrication of poly(norbornene)-based nanogels. exo-N-(Methoxypoly(ethylene glycol)) norbornene-
dicarboxyimide and exo-norbornene-carboxylic acid-pentafluorophenyl ester are block copolymerized under ring-opening metathesis conditions.
The resulting amphiphilic reactive ester block copolymers self-assemble in DMSO into precursor micelles, whose cores can be functionalized by
mono-amine-bearing entities, cross-linked with pH-(non)-degradable bisamines, and finally converted into fully hydrophilic nanogels. Ketal cross-
linking promotes pH-responsive particle disassembly upon exposure to endolysosomal pH affording single, non-cross-linked soluble polymers.
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μm; porosity, 100 and 1000 Å. Calibration was carried out with
poly(methyl methacrylate) (PMMA) standards, purchased from PSS,
Mainz.
Matrix-assisted laser desorption ionization time-of-flight (MALDI-
ToF) mass spectra were acquired on a rapifleXTM MALDI-ToF/ToF
mass spectrometer from Bruker equipped with a 10 kHz scanning
smartbeam three-dimensional (3D) laser (Nd:YAG at 355 nm) and a
10 bit 5 GHz digitizer. Measurements were performed in a positive
reflector mode using DCTB (trans-2-[3-(4-tbutylphenyl)-2-methyl-2-
propenylidene]malononitrile) acid as a matrix and the obtained data
processed by mMass software.
Transmission electron microscopy (TEM) images were prepared
by adding 4 μL of the nanogel/polymer solution at 2 mg/mL in water
(supplemented with 0.1% conc. aqueous ammonia) onto a carbon-
coated copper grid. After drying in air for 10 min, the remaining
solution was removed by a filter paper. After further drying in air, the
measurement was conducted on a JEOL JEM-1400 TEM operating at
an accelerating voltage of 120 kV.
UV−vis spectra were recorded on a Jasco V-630 spectropho-
tometer equipped with a Peltier thermostatted single-cell holder
(JASCO ETC-717) cooled by a water thermostat (A. Knüss Optronic
V50) to guarantee measurement conditions at 25.0 °C.
Fluorescence and cell assay recorded absorbance intensities were
also monitored on a Tecan Spark 20 M microplate reader.
Flow cytometry analyses were performed on a BD Accuri, and the
obtained data were processed using the FlowJo software package.
Fluorescence nonconfocal microscopy images were recorded on a
Leica DMi8 microscope with a 100× oil immersion objective.
Fluorescence confocal laser scanning microscopy images were
recorded on a Leica SP5 confocal microscope system with a 63×
oil immersion objective. All images were processed by ImageJ
software.
Materials. Unless otherwise mentioned, all chemicals were
purchased from Sigma-Aldrich, Tokyo Chemical Industry, or Acros
Organics and used as received. 1-(4-(Aminomethyl) benzyl)-2-butyl-
1H-imidazo[4,5-c]quinolin-4- amine (IMDQ) could be provided
according to an earlier report.31 Dialysis was performed using
Spectra/Por 3 membranes obtained from Spectrum Labs with a
molecular weight cutoff of 1000 g/mol.
Dulbecco’s phosphate-buffered saline (PBS), cell culture medium,
and supplements were purchased from Thermo Fisher. The RAW-
Blue reporter cell line and QUANTI-BlueTM were obtained from
InvivoGen.
Monomer Synthesis. Synthesis of exo-N-(Methoxypoly-
(ethylene glycol)) Norbornene-dicarboxyimide 2. The synthesis of
Figure 2. (A) Synthetic scheme for different polymerization sequences of poly(mPEG-Nb)-b-poly(Pfp-Nb) block copolymers. exo-N-
(Methoxypoly(ethylene glycol)) norbornene-dicarboxyimide 2 and exo-norbornene-carboxylic acid-pentafluorophenyl ester 3 are block
copolymerized under ring-opening metathesis conditions catalyzed by the fast initiating ruthenium metathesis catalyst 1 (Grubbs third-generation
catalyst). (B) 1H NMR and 19F NMR (black box) of the isolated poly(mPEG-Nb)-b-poly(Pfp-Nb) block copolymers. (C) SEC traces of the
respective block- and homopolymers with hexafluoroisopropanol (HFIP) as eluent.
Biomacromolecules pubs.acs.org/Biomac Article
https://dx.doi.org/10.1021/acs.biomac.0c00205
Biomacromolecules 2020, 21, 2246−2257
2248
the solvophilic mPEG-containing monomer was adapted from the
literature32 (Scheme S1). A solution of exo-[2.2.1]bicyclo-2-ene-5,6-
dicarboxylic anhydride (0.43 g, 2.61 mmol, 1.0 equiv) and mPEG-
amine 0.5 kDa (1.34 g, 2.61 mmol, 1 equiv) in toluene (50 mL) was
heated at reflux overnight. The reaction mixture was then cooled to
room temperature, and the solvent was evaporated under reduced
pressure. The crude reaction product was purified via column
chromatography (CHCl3/MeOH 10:1). Product 2 was obtained as a
yellow oil in 95% yield (1.64 g, 2.51 mmol).
1H NMR (300 MHz, CDCl3) δ [ppm] = 6.26 (t, J = 1.9 Hz, 2H),
3.71−3.49 (m, 44H), 3.36 (s, 3H), 3.25 (p, J = 1.7 Hz, 2H), 2.66 (d, J
= 1.3 Hz, 2H), 1.47 (dt, J = 9.8, 1.6 Hz, 1H), 1.34 (dt, J = 9.9, 1.6 Hz,
1H) (Figures S1 and S3).
13C NMR (75 MHz, CDCl3) δ [ppm] = 178.12, 137.93, 72.03,
70.68, 69.96, 66.99, 59.14, 47.92, 45.37, 42.82, 37.8 (Figures S2, S4,
and S5).
Synthesis of exo-Norbornene-carboxylic Acid-Pentafluorophenyl
Ester 3. The procedure was adapted from the literature33 (Scheme
S2). Pentafluorophenol (2.62 g, 18.9 mmol, 1 equiv) and exo-
[2.2.1]bicyclo-2-ene-5-carboxylic acid (3.84 g, 20.8 mmol, 1.1 equiv)
(that was first isolated from a mixture of exo and endo species
compare Supporting Information and Scheme S2) were dissolved in
anhydrous dichloromethane (DCM) (25 mL) and cooled to 0 °C.
Dicyclohexylcarbodiimide (DCC) (4.31 g, 20.9 mmol, 1.1 equiv) was
added to the solution, and dimethylaminopyridine (DMAP) (0.23 g,
1.9 mmol, 0.1 equiv) dissolved in anhydrous DCM (2 mL) was added
slowly via a syringe. After 1 h, the reaction mixture was allowed to
warm to room temperature and stirred overnight. After 20 h, the
volatiles were removed in vacuo and the crude reaction mixture was
purified by column chromatography (CHex/EtOAc 20:1) to yield
5.19 g (17.1 mmol, 90.3%) of 3 as a pale yellow oil.
1H NMR (300 MHz, CDCl3): δ 6.23 (dd, J = 5.7, 2.9 Hz, 1H,),
6.18 (dd, J = 5.7, 3.0 Hz, 1H), 3.27 (ddq, J = 3.1, 1.5, 0.8 Hz, 1H),
3.03 (s, 1H), 2.59 (ddd, J = 9.0, 4.5, 1.5 Hz, 1H), 2.16−1.89 (m, 1H),
1.60−1.55 (m, 1H), 1.54 (t, J = 1.7 Hz, 1H), 1.52−1.47 (m, 1H)
(Figures S6 and S8).
13C NMR (75 MHz, CDCl3): δ 172.56, 138.68, 135.46, 47.16,
46.54, 42.87, 41.95, 30.88 (Figures S7, S9, and S10).
19F NMR (376 MHz, CDCl3) δ −154.26 (d, J = 17.7 Hz), −159.52
(t, J = 21.7 Hz), −163.64 (dd, J = 22.0, 17.6 Hz) (Figure S11).
Polymerization Procedure. The procedure was adapted from
the literature and modified.26 In an exemplified procedure, the block
copolymer synthesis of poly(mPEG-Nb)50-b-poly(Pfp-Nb)50 is
described: 0.13 mL of a 0.14 M stock solution of exo-N-
(methoxypoly(ethylene glycol)) norbornene-dicarboxyimide 2
(0.068 mmol, 44.0 mg, 65 equiv) in DCM was rapidly transferred
to a flame-dried Schlenk tube charged with 0.11 mL of a 0.13 M stock
solution of ruthenium initiator Grubbs third-generation catalyst 1
(0.001 mmol, 1.2 mg, 1.3 equiv) in DCM. After thin-layer
chromatography (TLC) showed a full conversion of exo-N-
(methoxypoly(ethylene glycol)) norbornene-dicarboxyimide 2, an
aliquot of the reaction mixture was removed (0.13 mL, corresponding
to 0.3 equiv of ruthenium initiator), terminated with ethyl vinyl ether
(EVE), and characterized by NMR spectroscopy and size exclusion
chromatography (SEC) (Figures S12 and S13). Then, 0.38 mL of a
0.14 M stock solution of exo-norbornene-carboxylic acid-pentafluor-
ophenyl ester 3 (0.053 mmol, 16.0 mg, 50 equiv) in DCM was added
to the reaction vial to proceed block copolymerization. After full
second monomer consumption, as indicated by TLC, the reaction was
terminated by the addition of an excess of EVE. The resulting block
copolymer poly(mPEG-Nb)50-b-poly(Pfp-Nb)50 was precipitated
three times into cold hexane. Hexane was decanted, and the obtained
material was dried in vacuo. The polymers were analyzed by SEC, 1H
NMR, and 19F NMR (Figures 2, S14, and S15).
1H NMR (300 MHz, CDCl3): δ 5.85−5.65 (br, 1H,), 5.60−5.45
(br, 1H), 5.45−5.20 (br, 2H), 3.71−3.49 (m, 44H), 3.36 (s, 3H),
3.33−2.60 (m, 7H), 2.35−1.75 (m, 5H), 1.55−1.47 (br, 1H) (Figure
2B).
19F NMR (375 MHz, CDCl3): δ −154.35 (br, 2H), −159.48 (br,
1H), −163.84 (br, 2H) (Figure S2B).
Nanogel Formation. Block Copolymer Self-Assembly. The
desired block copolymer (10 mg, 13.6 μmol reactive ester for
poly(mPEG-Nb)50-b-poly(Pfp-Nb)50) was dispersed in anhydrous
DMSO, yielding a 10 mg/mL solution. Subsequent sonication (1−8
h) resulted in the formation of self-assembled polymeric micelles, as
verified by DLS measurements, and micellar dispersions were used for
further nanogel synthesis.
Core Functionalization of Polymeric Micelles. The synthesis of
three different types of nanogels (ketal-cross-linked, ether-cross-
linked, and non-cross-linked) was performed by dispersing the desired
amount of pentafluorophenyl ester-containing polymeric micelle (1
mL, 13.6 μmol reactive ester) in anhydrous DMSO in a flame-dried
Schlenk tube. The desired cross-linkers were added together with
triethylamine (0.61 mL of a 1.38 mg/mL stock solution, 8.3 μmol,
0.61 equiv) under a nitrogen atmosphere. The equivalents are
depicted in reference to amine functionality. 2,2-Bis(aminoethoxy)-
propane (0.6 mL of a 1.10 mg/mL stock solution, 4.1 μmol, 0.6 amine
equiv) was used for ketal cross-linking, while 1,2-bis(aminoethoxy)-
ethane (0.6 mL of a 1.01 mg/mL stock solution, 4.1 μmol, 0.6 amine
equiv) served as an ether cross-linker. In the case of non-cross-linking,
monomethoxy-poly(ethylene glycol)-amine 0.75 kDa (0.6 mL of a
10.21 mg/mL stock solution, 8.2 μmol, 0.6 amine equiv) was added.
The reaction mixture was stirred for 1 day at 40 °C. For the complete
removal of residual pentafluorophenyl reactive esters, the reaction was
quenched by the addition of monomethoxy-poly(ethylene glycol)-
amine 0.75 kDa (1.0 mL of a 10.21 mg/mL stock solution, 13.6 μmol,
1.0 amine equiv) and triethylamine (1.1 mL of a 1.38 mg/mL stock
solution, 15.0 μmol, 1.1 equiv) and stirred at room temperature for 1
day. Nanogels were then transferred into dialysis membranes
(MWCO: 3.5 kDa) and dialyzed against 1 L of water with 0.1%
ammonia for 3 days, changing the water two times per day.
Lyophilization afforded nanogels as colorless to brownish gooey
materials. The cross-linked particles were significantly more solid than
the non-cross-linked polymers, which were obtained as highly viscous
oils.
Fluorescently Labeled Nanogels. To 1 mL of the precursor
polymer (10 mg, 13.6 μmol reactive ester for poly(mPEG-Nb)50-b-
poly(Pfp-Nb)50) in anhydrous DMSO was added Oregon Green
cadaverine (14 μL of a 2.5 mg/mL stock solution in DMSO, 68 nmol;
0.005 equiv) and dry triethylamine (TEA) (10 μL of a 1.38 mg/mL
stock solution in DMSO, 136 nmol, 0.01 equiv) and stirred overnight
under a nitrogen atmosphere. After dye conjugation, the polymer
cross-linking was performed in analogy to the procedure described
above. Note that beyond dialysis, an additional spin filtration was
conducted to remove all residual free dye (MWCO 10 kDa, 0.1%
NH3-aqueous solution/MeOH 1:1), as confirmed by the quantitative
reversed-phase thin-layer chromatography (RP-TLC) (Figures S26−
S28).
IMDQ Conjugation to Nanogels. To 1 mL of the precursor
polymer (10 mg, 13.6 μmol reactive ester for poly(mPEG-Nb)50-b-
poly(Pfp-Nb)50) in anhydrous DMSO were added IMDQ (0.1 mL of
a 10 mg/mL stock solution in DMSO, 2.3 μmol; 0.17 equiv) and dry
TEA (0.2 mL of a 1.38 mg/mL stock solution in DMSO, 2.7 μmol,
0.2 equiv) and stirred overnight under a nitrogen atmosphere. After
drug conjugation, the polymer cross-linking was performed in analogy
to the procedure described above. Here, beyond dialysis, additional
spin filtration was not necessary to remove all residual free drug, as
confirmed by quantitative reverse phase thin-layer chromatography
(RP-TLC) (Figures S34−S36).
Cellular Uptake, TLR Stimulation, and Viability. RAW-Blue
macrophages were cultured in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% fetal bovine serum, 2 mM L-
glutamine, 1 mM sodium pyruvate, 1% penicillin/streptomycin, 0.01%
normocin, and 0.02% zeocin as selection medium. The cells were kept
at 37 °C with 5% CO2 saturation.
RAW-Blue Macrophage TLR Reporter Assay. IMDQ TLR receptor
stimulation followed by NF-kB/AP-1 activation was monitored by
secretion of embryonic alkaline phosphatase from RAW-Blue cells, as
recommended by the manufacturer (InvivoGen). The RAW-Blue cells
were seeded into 96-well plates at a density of 90 000 cells/well in 180
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μL of culture medium. Each well was treated with 20 μL of a nanogel
sample at the given final IMDQ concentrations (and corresponding
empty nanogel or other control concentrations). After incubation for
18 h, 50 μL of the supernatant from each well was collected and
tested for secreted embryonic alkaline phosphatase (SEAP) using the
QUANTI-Blue assay (InvivoGen). QUANTI-Blue (150 μL) was
added to each sample and incubated at 37 °C. SEAP levels were
determined by measuring the optical density at 615 nm using a
microplate reader. The activity was determined by an increase in the
optical density relative to the negative control treated with PBS. All
experiments were conducted at n = 4.
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium Bromide
(MTT) Assay. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) (50 μL, 0.5 mg/mL in PBS) was added to the
RAW-Blue cells that were treated with nanogel samples at the given
final IMDQ concentrations (and corresponding empty nanogel
concentrations), as described before. After an incubation period of
2−3 h, the formed formazan crystals were dissolved by the addition of
100 μL 10% m/v SDS/0.01 M HCl and incubated overnight at 37 °C.
Quantification was done by measuring the absorbance at 570 nm
using a microplate reader.
Flow Cytometry. RAW-Blue macrophages were seeded into 24-
well titer plates (250 000 cells/well, suspended in 0.90 mL of culture
medium) and incubated overnight to allow cell sedimentation and
subsequent adhesion to the bottom of the wells. Next, the cells were
incubated with 100 μL of Oregon Green labeled nanogel or polymer
solution in PBS (yielding a total polymer/nanogel concentration of
either 30 or 100 μg/mL). All samples were run in triplicate, and the
experiment was conducted for 18 h at 37 °C. The cell culture medium
was then aspirated, and the cells were washed with 1 mL of PBS and
incubated with 400 μL of a cell dissociation buffer (15 min, 37 °C).
The cell suspensions were then diluted with 400 μL of cell culture
medium, transferred into Eppendorf tubes, and centrifuged
immediately (350g, 10 min, 5 °C). Finally, the supernatant was
aspirated and the cell pellets were suspended in 250 μL of PBS. They
were kept on ice to maintain cell integrity prior to flow cytometric
analysis performed on a BD Accuri C6 (BD Biosciences). The data
were processed by FlowJo software.
Fluorescence Microscopy. RAW-Blue macrophages were seeded in
an Ibidi μ-slide eight-well confocal microscopy chamber (50 000
cells/well, suspended in 0.18 mL of the culture medium) and left to
adhere overnight. Next, the cells were incubated with 20 μL of
Oregon Green labeled nanogel or polymer solution in PBS (yielding a
total polymer/nanogel concentration of 100 μg/mL) for 24 h. Then,
the culture medium was aspirated and the cells were washed three
times with PBS. Next, 200 μL of 4% paraformaldehyde was added and
allowed to fixate for 15 min at 37 °C. Afterward, the cells were washed
again three times with PBS and their nuclei were stained with 200 μL
of 4′,6-diamidino-2-phenylindole (DAPI) (80 μg/mL in PBS) for 10
min at 37 °C. Finally, the cells were washed once more three times
with PBS and then stored under an aqueous mounting medium. First,
nonconfocal fluorescence microscopy images were recorded on a
Leica DMi8 microscope with a 100× oil immersion to confirm
particle or polymer uptake. Then, to prove internalization of the
material into the cells, fluorescence confocal laser scanning
microscopy images were recorded on a Leica SP5 confocal
microscope system with a 63× oil immersion objective. All images
were finally processed by the ImageJ software package.
■ RESULTS AND DISCUSSION
We previously reported on immune stimulatory nanogels,
based on reactive amphiphilic poly(methacrylamide) block
copolymers derived from mPEG- and pentafluorophenyl ester-
bearing acrylates, that can be prepared by RAFT polymer-
ization and subsequent versatile postpolymerization modifica-
tion.22 Prior to this study, we investigated other polymerization
techniques and monomer systems and thereby observed that,
in analogy to our previously reported studies, the ring-opening
metathesis polymerization (ROMP) of norbornenes with
mPEG or pentafluorophenyl ester side chains can provide
rapid access to highly modifiable, pH-degradable nanogels. In
this study, we introduce this carrier system for the first time
and observed that covalent modification with the TLR7/8
agonist IMDQ31 provides immune stimulatory properties only
for the intact particles, while converted into single polymer
chains, a loss in activity and conversion into immunologically
silent species make the whole delivery system highly attractive
for clinical purposes.
Synthesis of Poly(norbornene) Precursor Block
Copolymers. Due to their high activity during metathesis
reactions, substituted exo-norbornenes were chosen as
monomers and derivatized to provide characteristics for
amphiphilic reactive ester block copolymers. The attachment
of an mPEG-amine to norbornene dicarboxylic anhydride
provides access to the solvophilic monomer 2. Furthermore,
PEG is known for its biocompatibility and stealth effect in vivo,
which is a vital feature in achieving long blood circulation
times.34−36 Alternatively, norbornene carboxylic acid-penta-
fluorophenyl ester 3 serves as an amine reactive precursor, and
due to its highly fluorinated character, it additionally provides
phase separation properties in polar aprotic media.11
A scheme for the syntheses of the monomers can be found
in the Supporting Information (Schemes S1 and S2). N-
(Poly(ethylene glycol))-cis-5-norbornene-exo-2,3-dicarboxi-
mide 2 was directly accessed starting from commercially
available exo-norbornene carboxylic anhydride. Upon con-
densation reaction with an amino-capped methoxy-poly-
(ethylene glycol) in toluene, exo-imide 2 was obtained in
nearly quantitative yield and confirmed by 1H and 13C NMR,
as well as COSY, HSQC, and HMBC measurements (Figures
S1−S5).
In general, exo-isomers are usually the ones with higher
reactivity during ROMP;37−40 however, toward the synthesis of
exo-norbornene-5-carboxylic acid-pentafluorophenyl ester 3,
the starting material norbornene-5-carboxylic acid is only
commercially available as a mixture of 80% endo-isomer and
20% exo-isomer, as determined by 1H NMR. However, when
treated with iodine and KI, the formation of an iodolactone is
possible, yet, exclusively for the endo-acid. Consequently, in a
simple purification step, the exo-acid could be extracted from
the endo-derived iodolactone, as described in the Supporting
Information, and subsequently esterificated with pentafluor-
ophenol under Steglich conditions with DCC and DMAP.41,42
The resulting exo-norbornene-5-carboxylic acid-pentafluoro-
phenyl ester 3 was obtained in 90% yield and characterized by
1H, 13C, and 19F NMR, as well as COSY, HSQC, and HMBC
measurements (Figures S6−S11).
For the controlled synthesis of homo and block copolymers,
the fast initiating bromopyridine ruthenium catalyst 1 was
chosen (Figure 2A). The high functional group tolerance and
especially the fast initiation kinetics of the ruthenium complex
during ROMP43 enables living polymerization conditions and
narrow molecular weight distributions.25 Due to the living
nature, block copolymers could, therefore, be obtained directly
in a one-pot manner after full first block monomer
consumption. Here, the monomer conversion was monitored
by TLC and NMR analyses to be nearly quantitative, which
shows the high activity of the catalyst and the norbornene
monomers.
Consequently, molecular weights could be easily tuned by
adjusting the initiator-to-monomer ratio (e.g., compare SEC
traces of the homopolymers of 2 in Figure S13), and the
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resulting polymers provide a high end-group fidelity, as
confirmed by their MALDI spectra (Figure S12A−C).
As homopolymers from monomer 2 were prepared readily,
block copolymerization was subsequently performed by adding
Pfp monomer 3 to the reaction vessel after a complete
monomer conversion. Also, the reverse polymerization
sequence was conducted successfully and afforded block
copolymers of similar properties (Figure 2A). Different
molecular weights of homo and block copolymers could be
obtained and successfully characterized by 1H NMR, 19F
NMR, and SEC analyses (Figures 2B,C and S14). Broad
signals at δ = 5.8−5.2 indicate the appearance of polymeric
olefinic protons. The signal at δ = 5.8 was assigned to the
solvophilic block and used to calculate the block ratio. The
signal of the olefinic protons at δ = 3.4 verifies the
incorporation of the mPEG side chain, and the appearance
of broad signals in the 19F NMR spectra shows the
polymerization of the solvophobic Pfp monomer 3 (Figure
2B). The shift in the elution volume for the subsequent
polymerization of solvophilic monomer 2 onto a block of
monomer 3 is significantly larger than for the reverse
polymerization sequence due to the difference in molecular
weight of the incorporated monomers themselves (Figure 2C).
Further confirmation of complete chain extension could be
derived from diffusion ordered NMR spectroscopy (DOSY)
measurements (Figure S15). A complete shift of diffusion units
for all proton signals in the NMR spectra from the homo to
block copolymer confirmed the successful block copolymer
formation.
The molecular weight of the block copolymer could be
varied from 22 to 190 kDa by adjusting the monomer-to-
initiator ratio. Also, polymers with different block ratios (as
determined by 1H NMR) could be prepared successfully. The
results are all summarized by Table 1.
Interestingly, all block copolymers could be readily prepared
with reaction times ranging from 10 to 30 min per block. This
is one of the most significant advantages compared to the more
difficult and longer (usually days) reaction procedures
necessary for controlled radical block copolymerization
processes. Moreover, the block copolymerization could be
conducted in a one-pot manner and, thus, only a single
purification step was required to isolate the precursor block
copolymers for the subsequent nanogel fabrication.
Self-Assembly of Poly(norbornene) Precursor Block
Copolymers. In analogy to the previously published poly-
(methacrylamide) nanogels, the poly(norbornene)-based block
copolymers were tested for their phase separation and self-
assembling behavior in polar aprotic solvents. The solvophobic
pentafluorophenyl ester moiety is again immiscible with most
polar aprotic solvents including DMSO and, thus, enables
microphase separation and self-assembly of the block
copolymers into active-ester-containing polymeric micelles.
With increasing molecular weights of the respective block
copolymers, the size of the obtained precursor micelles
increases. The adjustment of particle size is, therefore,
conveniently achieved by variation of the monomer-to-initiator
ratio during the synthesis of the block copolymers. The
differently composed micelles in DMSO were characterized by
dynamic light scattering (DLS), and the results are shown in
Figure 3.
The self-assembly of the obtained polymers provided
differently sized micelles in the range of 40−190 nm
depending on the molecular weight and block ratios of the
respective polymer. With increasing molecular weight but the
same 1:1 block ratio, the size of the polymeric micelles
increases (as shown in Figure 3A). By reducing the molecular
weight of the solvophilic mPEG-containing block, the size of
the obtained particles decreases and the PEG corona becomes
smaller (as shown in Figure 3B).
Synthesis Poly(norbornene)-Based Nanogels. The
active-ester-containing polymeric micelles were then treated
with various bisamines as cross-linking agents to stabilize their
morphology while changing the core polarity from hydro-
phobic to hydrophilic. A ketal-bond-containing bisamine
should introduce a pH-sensitive trigger for the disassembly
of the nanogels, whereas an ether-bond-containing bisamine
should be insensitive toward acidic media. Furthermore,
residual Pfp ester moieties, after cross-linking, were first
substituted with ethanolamine. The small hydroxy group-
bearing amine was chosen as a solubilizing group in analogy to
the known poly(methacrylamide) systems. However, due to
the high hydrophobicity of the hydrocarbon backbone, the
non-cross-linked polymers still showed micellar self-assembly
in PBS after ethanolamine treatment (Figure S16). Only when
dispersed in DMSO, single polymer chains could be monitored
(Figure S17). For the nanogels, ketal cross-linking could be
degraded under acidic conditions in DMSO (Figure S18).
Therefore, in subsequent experiments, treatment with
ethanolamine was replaced by a short oligomer mPEG-amine
(0.75 kDa) to assure increasing nanogel core polarity and
single-chain solubility for the non-cross-linked version.
Altogether, Pfp ester substitution of cross-linked and non-
cross-linked particles with the hydrophilic mPEG-amine
(Figure 4A) lead to fully water-soluble polymers and
degradation of ketal-cross-linked particles under mild endo-
somal acidic media, as monitored by DLS measurements
(Figure 4B).
Moreover, covalent core cross-linking of the self-assembled
block copolymer micelles was further confirmed by trans-
mission electron microscopy (TEM) of samples drop-cast onto
the grids (Figure 4C and Supporting Information Figures
S19−S21). Only for the core-cross-linked nanogels, particular
structures with a high electron density could be visualized. For
the poly(Pfp-Nb)50-b-poly(mPEG-Nb)50-derived ether-cross-
linked nanogels, sizes of around 20−60 nm were found, while
the non-cross-linked species provided only structures below 15
nm representing single polymer chains (Figure 4C2).
Interestingly, for the ether-cross-linked nanogels, also a
core−shell-like morphology was fairly visible (Figure 4C1).
To further study the nanoparticle behavior upon exposure to
extracellular and endolysosomal pH over time, samples were








poly(mPEG-Nb)10-b-poly(Pfp-Nb)50 21 775 56 000 1.15
poly(mPEG-Nb)20-b-poly(Pfp-Nb)50 28 235 70 000 1.21
poly(mPEG-Nb)50-b-poly(Pfp-Nb)50 47 615 117 000 1.28
poly(Pfp-Nb)50-b-poly(mPEG-Nb)50 47 615 99 000 1.27
poly(mPEG-Nb)100-b-poly(Pfp-
Nb)100
95 125 145 000 1.34
poly(mPEG-Nb)200-b-poly(Pfp-
Nb)200
190 146 198 000 1.59
aDetermined by HFIP-SEC (PMMA standard).
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prepared at 1 mg/mL in PBS at pH 7.4 or in 100 mM acetate
buffer at pH 5.0 and continuously monitored by DLS
measurements. Only for the ketal-cross-linked nanogels at
pH 5.0, a decrease in count rate and a shift in particle size and
distribution toward smaller non-cross-linked soluble polymers
were found, while the particles remained stable in PBS for 24 h
(Figure 4D). Ether-cross-linked nanogels retained their
scattering intensity and size distribution in both media as
well as the non-cross-linked soluble polymers (Figures S22−
S24). In analogy to our previous studies,23 these results
confirm that nanogel unfolding for ketal-cross-linked polymer
micelles into single polymer chains can only occur intra-
cellularly at endolysosomal pH, but they remain intact at
neutral physiological pH.
Immune Stimulatory Properties of IMDQ-Loaded
Poly(norbornene)-Based Nanogels. Due to the penta-
fluorophenyl ester approach, pharmacologically active mole-
cules or fluorogenic tracer molecules with a single primary
amine can easily be attached via amide formation into the
micelle core for both therapeutic and diagnostic purposes.
Especially for immunodrug delivery, nanocarriers with sizes
smaller than 100 nm and sufficient PEG shielding provide ideal
properties to, e.g., efficiently reach and accumulate in draining
lymph nodes.21 For that purpose, the poly(mPEG-Nb)50-b-
poly(Pfp-Nb)50 block copolymer system was chosen and
converted into degradable or nondegradable nanogels and
soluble polymers (Figures 3A and 4B) for the following
immunodrug delivery studies (Figures 5 and 6).
To first investigate cellular toxicity and uptake, precursor
micelles were treated with the amine-bearing fluorescent dye
Oregon Green cadaverine (Figure 5A) prior to cross-linking
with ketal- or ether-containing bisamines, as well as hydro-
philization with mPEG-amine (Figure S25). Purification was
conducted by dialysis and spin filtration to remove all residual
free dye (MWCO 10 kDa, 0.1% NH3 aqueous solution/MeOH
1:1) and confirmed by quantitative reversed-phase thin-layer
chromatography (RP-TLC) (Figures S26−S28). The resulting
core-cross-linked nanogels or soluble polymer were all
equipped with Oregon Green as fluorescent tracer (Figure
5A−C).
The particles and polymers did not significantly differ in size
from species prepared without dye (Figure 5B), as determined
by DLS characterization in PBS, yet successful conjugation was
verified by UV−vis spectroscopy showing similar absorbance
maxima around 500 nm (Figure 5C).
All particles and polymers did not exhibit any major
influence on cell viability, as verified by MTT assay with
RAW-Blue macrophages at a particle concentration of up to
100 mg/L (Figure 5D). The RAW-Blue cell line was used in
this study as a model cell line for antigen-presenting cells,
which even allow a rapid screening of immune cell maturation
by the secretion of an embryonic alkaline phosphatase. This
was chromosomally integrated into this model cell line, and
upon TLR7/8 stimulation followed by NF-kB and AP-1
signaling, it is secreted into the cell supernatant and can be
quantified spectrophotometrically as an indicator for immune
stimulation.
This cell line was further used to study the uptake of the
Oregon Green labeled species using flow cytometry and
fluorescence (confocal) microscopy. RAW-Blue macrophages
were treated with similar amounts of material, as referred to
the absorbance/fluorescence intensities of Oregon Green
(Figure S29). Ketal- or ether-cross-linked nanogels (30 and
100 μg/mL, respectively) as well as non-cross-linked soluble
polymers were applied to the cells and incubated for 24 h prior
to flow cytometric analysis (its gating strategy can be found in
Figure S30). The resulting histograms in Figure 5E1 and mean
fluorescence intensities in Figure 5E2 show moderate but
similar cell uptake for all different nanogel and polymer
species. This uptake was also dose-dependent and could be
increased for the incubation concentration from 30 to 100 μg/
mL.
These findings could also be confirmed by fluorescence
microscopy, where an association of Oregon Green labeled
material was observed for the RAW-Blue macrophages treated
with all three different species for 24 h at 100 μg/mL (Figure
S31). Through confocal laser scanning microscopy, an
intracellular localization of the nanogels or soluble polymers
by the presence of Oregon Green labeled species insides cells
was found (Figures 5F and S32), indicating identical
internalization of all species into the cells probably via
endocytotic pathways.
In analogy to the preparation of these nontoxic dye-
functionalized nanogels and soluble polymers, similar
fabrication conditions were applied for the conjugation of
the small-molecule imidazoquinoline TLR agonist IMDQ31 to
Figure 3. DLS measurements of self-assembling poly(mPEG-Nb)-b-poly(Pfp-Nb) block copolymers in DMSO. (A) Polymeric micelles, obtained
from block copolymers with increasing molecular weight and 1:1 block ratios. (B) Polymeric micelles obtained from block copolymers with
decreasing molecular weight of the solvophilic block but the same solvophobic block.
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improve its pharmacokinetic behavior. Prior to cross-linking
and hydrophilization with mPEG-amine, the substitution of
Pfp units with the amine-containing IMDQ was performed
(Figure S33). After purification by excessive dialysis, IMDQ-
conjugated soluble polymers, as well as pH-sensitive nanogels
and nondegradable nanogels were obtained (Figure 6). No
free, unbound IMDQ could be found in the cross-linked
nanogel or non-cross-linked polymers, as determined by the
quantitative reversed-phase thin-layer chromatography (RP-
TLC) (Figures S34−S36), yet the amount of covalently
attached IMDQ was verified by UV−vis spectroscopy and a
comparison of the imidazoquinoline absorbance maximum
Figure 4. (A) Substitution of Pfp esters with bisamine cross-linkers and/or short oligo mPEG amines affording hydrophilic nanogels/water-soluble
polymer chains. (B) DLS characterization of the resulting cross-linked nanogels and non-cross-linked polymers in PBS derived from poly(Pfp-
Nb)50-b-poly(mPEG-Nb)50 precursor micelles, as well as their response upon lowering the pH to endosomal levels of pH 5. Note that only the
ketal-cross-linked nanogels disassemble into single polymer chains exclusively. (C) TEM images of soluble polymer chains and nondegradable
ether-cross-linked nanogels (1) and their derived counted size distributions (2). (D) DLS monitoring of ketal-cross-linked particle stability at
extracellular pH and degradation at endolysosomal pH. Particle scattering intensity (1), particle size (2), and size distribution (3) decrease over
time under mild acidic conditions (100 mM acetate buffer, pH 5.0), while the ketal-cross-linked particle’s integrity is guaranteed under neutral
conditions (PBS, pH 7.4) for 24 h (compare also Figures S22−S24).
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around 327 nm allowed the determination of the covalent drug
load (Figure 6A; detailed information can be found in
Supporting Information Figure S37 and Table S1). About
3−4 wt % drug load could be quantified for all species.
Interestingly, covalent drug load did not have any significant
impact on particle size and distribution of the ketal- or ether-
cross-linked nanogels (Figure 6B and S38). Only the non-
cross-linked soluble polymer chains tend again to self-assemble
in water after IMDQ conjugation, which is probably due to the
slight decrease in hydrophilicity caused by the ligated
imidazoquinoline (Figures 6B and S38). Nonetheless, for the
ketal-cross-linked nanogels, degradation was still confirmed
upon exposure to acidic media, as similar size distributions
were obtained for the non-cross-linked IMDQ-conjugated
polymers (Figure S39).
To test the ability for TLR activation, RAW-Blue macro-
phages were finally incubated with the prepared IMDQ-loaded
particles for 18 h and then characterized. As previously stated,
all RAW-Blue macrophages exhibit chromosomal integration of
the secreted embryonic alkaline phosphatase reporter con-
struct, which is induced by NF-kB and AP-1. The activation of
TLR-7/8 by IMDQ leads to the activation of the downstream
signaling cascade and eventually to the release of NF-kB. The
secretion of the alkaline phosphatase in turn is utilized for the
spectrometric quantification of TLR activation. During these
experiments, a decrease in cellular viability could be found for
neither the empty nanogels and polymers nor the IMDQ drug
species, as characterized by the MTT assay simultaneously
(Figure S40).
A readout of the cell culture supernatant media revealed a
similar dose-dependent activation of TLR for nondegradable
Figure 5. (A) Synthetic scheme for the substitution of Pfp esters in the polymeric precursor micelle cores with Oregon Green cadaverine and
different cross-linkers and/or mPEG-amine as hydrophilizing agent. (B) DLS characterization of poly(Pfp-Nb)50-b-poly(mPEG-Nb)50-derived
cross-linked nanogels and non-cross-linked polymers with and without fluorescent dye. (C) UV absorbance of dye-conjugated nanogels and
polymers compared to nonlabeled species. (D) Cell viability assay (MTT) of RAW-Blue macrophages incubated with cross-linked nanogels and
non-cross-linked polymers at increasing concentrations for 18 h (n = 4). (E) Flow cytometry histograms (1) and mean fluorescence intensities
(MFI) (2) of RAW-Blue macrophages incubated with Oregon Green labeled cross-linked nanogels and non-cross-linked polymers at 30 mg/L and
100 μg/mL for 18 h (n = 3). (F) Confocal laser scanning fluorescence microscopy images of RAW-Blue macrophages incubated with Oregon
Green labeled cross-linked nanogels and non-cross-linked polymers at 100 μg/mL for 24 h (green: Oregon Green labeled polymer or nanogel
species; blue: nuclei stained with DAPI; gray: dark field image for cell morphology; scale bar: 10 μm).
Biomacromolecules pubs.acs.org/Biomac Article
https://dx.doi.org/10.1021/acs.biomac.0c00205
Biomacromolecules 2020, 21, 2246−2257
2254
nanogels and acid-labile, ketal-cross-linked nanogels. While the
half-maximal effective concentration (EC50) of the free,
nonconjugated IMDQ is around 0.02 μM, the activity of the
particle-bound IMDQ is about 1 order of magnitude weaker
(0.2 μM) for both acid-labile and nondegradable nanogels
(Figure 6C). The decrease of activity in nanoparticulate
formulation of the drug is comparable to the decrease observed
for the poly(methacrylamide)-based nanogels (Figure 6D).
Also, the soluble IMDQ-loaded poly(methacrylamide) poly-
mers show a reasonable activity around 0.2 μM. However, in
contrast to these systems, the non-cross-linked, soluble IMDQ-
loaded, metathesis-derived poly(norbornene)s do not show
any significantly high activity in the cell experiments (Figure
6C, green curve). We speculate on different intracellular
trafficking mechanisms for these polymers causing this
clinically beneficial effect. Further investigation on the
intracellular fate of this polymeric material should provide
more insight into this behavior.
To conclude, as the poly(norbornene)-based IMDQ nano-
gels can be degraded under acidic endosomal pH conditions
into non-cross-linked soluble polymers, they are first
immunologically active but then fall apart into immunologi-
cally silent, soluble polymers. This behavior allows a unique
access to both temporal and spatial control over the IMDQ
activity. The carriers seem to support IMDQ’s TLR7/8
stimulation only in their nanoparticular form. Unwanted
systemic activation of the immune system seems to be turned
off upon nanogel degradation into soluble polymers.
Elimination of soluble polymers from the tumoral tissue and
its draining lymph nodes into the blood circulation followed by
excretion via the kidneys can further prevent long-term
overstimulation of the immune system as well as unfavorable
carrier accumulation in the body.44 Altogether, this may
regulate IMDQ’s high immune stimulatory potency and
facilitate its translatability for cancer immunotherapy.
■ CONCLUSIONS
In summary, for the first time, the synthetic approach of
poly(norbornene)-based, pH-degradable core-cross-linked
nanogels is introduced in this study. For this purpose, block
copolymers of mPEG- and pentafluorophenyl ester-containing
poly(norbornene)s could be synthesized with a fast initiating
Grubbs catalyst (third generation). The phase separation
behavior of the fluorinated reactive ester block in DMSO
resulted in reactive micellar particles of adjustable sizes
according to the molecular weight and block ratio of the
underlying precursor block copolymers.
The reactive ester core-containing micelles were utilized for
cross-linking with hydrophilic, pH-sensitive ketal-containing
bisamines or a nondegradable ether bisamines instead.
Alternatively, non-cross-linked, fully water-soluble species
were obtained by treatment with short oligo mPEG amines.
However, the degradation of the cross-linked nanogels into
soluble polymeric chains was only observed under endosomal
pH conditions for the ketal-cross-linked species.
Moreover, the active esters inside the micelle core could
further be used for conjugation of fluorescent tracer molecules
(for studying cell uptake by flow cytometry and confocal laser
scanning fluorescence microscopy) or the highly immune
stimulatory small-molecule imidazoquinoline TLR agonist. All
carriers exhibited only very low toxicity during cell viability
assays. Yet, the immune-modulating activity of drug-
conjugated carriers was tested in vitro with RAW-Blue
Figure 6. (A) UV−vis spectra for the determination of covalent IMDQ loading to ketal- and ether-cross-linked nanogels as well as non-cross-linked
soluble polymers derived from poly(Pfp-Nb)50-b-poly(mPEG-Nb)50 precursor micelles. (B) DLS measurements of the IMDQ-loaded nanogels
and polymers in PBS, compared to the nonloaded species. (C) Results of the TLR stimulation of RAW-Blue macrophages treated with the
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macrophages. Interestingly, the activity of IMDQ-conjugated
non-cross-linked polymers was decreased drastically, in
contrast to nanoparticulate IMDQ. As also acid-degradable
ketal particles were designed that fall apart into single
polymers, these systems would enable beyond spatial also a
temporal control over the immune-modulating activity of
IMDQ and, thus, provide access to novel safe and controllable
polymeric delivery strategies for such highly potent and
promising drugs in cancer immunotherapy.
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(15) Jewell, C. M.; Loṕez, S. C. B.; Irvine, D. J. In situ engineering of
the lymph node microenvironment via intranodal injection of
adjuvant-releasing polymer particles. Proc. Natl. Acad. Sci. U.S.A.
2011, 108, 15745−15750.
(16) Liu, H.; Moynihan, K. D.; Zheng, Y.; Szeto, G. L.; Li, A. V.;
Huang, B.; van Egeren, D. S.; Park, C.; Irvine, D. J. Structure-based
programming of lymph-node targeting in molecular vaccines. Nature
2014, 507, 519−522.
(17) Moon, J. J.; Suh, H.; Bershteyn, A.; Stephan, M. T.; Liu, H.;
Huang, B.; Sohail, M.; Luo, S.; Um, S. H.; Khant, H.; Goodwin, J. T.;
Ramos, J.; Chiu, W.; Irvine, D. J. Interbilayer-crosslinked multi-
lamellar vesicles as synthetic vaccines for potent humoral and cellular
immune responses. Nat. Mater. 2011, 10, 243−251.
(18) Nembrini, C.; Stano, A.; Dane, K. Y.; Ballester, M.; van der
Vlies, A. J.; Marsland, B. J.; Swartz, M. A.; Hubbell, J. A. Nanoparticle
conjugation of antigen enhances cytotoxic T-cell responses in
pulmonary vaccination. Proc. Natl. Acad. Sci. U.S.A. 2011, 108,
E989−97.
(19) Reddy, S. T.; van der Vlies, A. J.; Simeoni, E.; Angeli, V.;
Randolph, G. J.; O’Neil, C. P.; Lee, L. K.; Swartz, M. A.; Hubbell, J. A.
Exploiting lymphatic transport and complement activation in
nanoparticle vaccines. Nat. Biotechnol. 2007, 25, 1159−1164.
(20) Lynn, G. M.; Laga, R.; Darrah, P. A.; Ishizuka, A. S.; Balaci, A.
J.; Dulcey, A. E.; Pechar, M.; Pola, R.; Gerner, M. Y.; Yamamoto, A.;
Buechler, C. R.; Quinn, K. M.; Smelkinson, M. G.; Vanek, O.;
Cawood, R.; Hills, T.; Vasalatiy, O.; Kastenmüller, K.; Francica, J. R.;
Stutts, L.; Tom, J. K.; Ryu, K. A.; Esser-Kahn, A. P.; Etrych, T.; Fisher,
K. D.; Seymour, L. W.; Seder, R. A. In vivo characterization of the
physicochemical properties of polymer-linked TLR agonists that
enhance vaccine immunogenicity. Nat. Biotechnol. 2015, 33, 1201−
1210.
(21) Nuhn, L.; van Hoecke, L.; Deswarte, K.; Schepens, B.; Li, Y.;
Lambrecht, B. N.; de Koker, S.; David, S. A.; Saelens, X.; De Geest, B.
G. Potent anti-viral vaccine adjuvant based on pH-degradable
nanogels with covalently linked small molecule imidazoquinoline
TLR7/8 agonist. Biomaterials 2018, 178, 643−651.
(22) Stickdorn, J.; Nuhn, L. Reactive-ester derived polymer nanogels
for cancer immunotherapy. Eur. Polym. J. 2020, 124, No. 109481.
(23) Nuhn, L.; van Herck, S.; Best, A.; Deswarte, K.;
Kokkinopoulou, M.; Lieberwirth, I.; Koynov, K.; Lambrecht, B. N.;
De Geest, B. G. FRET Monitoring of Intracellular Ketal Hydrolysis in
Synthetic Nanoparticles. Angew. Chem., Int. Ed. 2018, 57, 10760−
10764.
(24) Leber, N.; Kaps, L.; Aslam, M.; Schupp, J.; Brose, A.; Schaf̈fel,
D.; Fischer, K.; Diken, M.; Strand, D.; Koynov, K.; Tuettenberg, A.;
Nuhn, L.; Zentel, R.; Schuppan, D. SiRNA-mediated in vivo gene
knockdown by acid-degradable cationic nanohydrogel particles. J.
Controlled Release 2017, 248, 10−23.
(25) Choi, T.-L.; Grubbs, R. H. Controlled living ring-opening-
metathesis polymerization by a fast-initiating ruthenium catalyst.
Angew. Chem., Int. Ed. 2003, 42, 1743−1746.
(26) Matson, J. B.; Grubbs, R. H. Synthesis of fluorine-18
functionalized nanoparticles for use as in vivo molecular imaging
agents. J. Am. Chem. Soc. 2008, 130, 6731−6733.
(27) Roloff, A.; Nelles, D. A.; Thompson, M. P.; Yeo, G. W.;
Gianneschi, N. C. Self-Transfecting Micellar RNA: Modulating
Nanoparticle Cell Interactions via High Density Display of Small
Molecule Ligands on Micelle Coronas. Bioconjugate Chem. 2018, 29,
126−135.
(28) Nuhn, L.; Hirsch, M.; Krieg, B.; Koynov, K.; Fischer, K.;
Schmidt, M.; Helm, M.; Zentel, R. Cationic nanohydrogel particles as
potential siRNA carriers for cellular delivery. ACS Nano 2012, 6,
2198−2214.
(29) Leber, N.; Nuhn, L.; Zentel, R. Cationic Nanohydrogel
Particles for Therapeutic Oligonucleotide Delivery. Macromol. Biosci.
2017, 17, No. 1700092.
(30) Das, A.; Theato, P. Activated Ester Containing Polymers:
Opportunities and Challenges for the Design of Functional Macro-
molecules. Chem. Rev. 2016, 116, 1434−1495.
(31) Shukla, N. M.; Malladi, S. S.; Mutz, C. A.; Balakrishna, R.;
David, S. A. Structure-activity relationships in human toll-like receptor
7-active imidazoquinoline analogues. J. Med. Chem. 2010, 53, 4450−
4465.
(32) Veccharelli, K. M.; Tong, V. K.; Young, J. L.; Yang, J.;
Gianneschi, N. C. Dual responsive polymeric nanoparticles prepared
by direct functionalization of polylactic acid-based polymers via graft-
from ring opening metathesis polymerization. Chem. Commun. 2016,
52, 567−570.
(33) Zhang, K.; Lackey, M. A.; Wu, Y.; Tew, G. N. Universal cyclic
polymer templates. J. Am. Chem. Soc. 2011, 133, 6906−6909.
(34) Gref, R.; Minamitake, Y.; Peracchia, M. T.; Trubetskoy, V.;
Torchilin, V.; Langer, R. Biodegradable long-circulating polymeric
nanospheres. Science 1994, 263, 1600−1603.
(35) Torchilin, V. P.; Klibanov, A. L.; Huang, L.; O’Donnell, S.;
Nossiff, N. D.; Khaw, B. A. Targeted accumulation of polyethylene
glycol-coated immunoliposomes in infarcted rabbit myocardium.
FASEB J. 1992, 6, 2716−2719.
(36) Knop, K.; Hoogenboom, R.; Fischer, D.; Schubert, U. S.
Poly(ethylene glycol) in drug delivery: pros and cons as well as
potential alternatives. Angew. Chem., Int. Ed. 2010, 49, 6288−6308.
(37) Kanaoka, S.; Grubbs, R. H. Synthesis of Block Copolymers of
Silicon-Containing Norbornene Derivatives via Living Ring-Opening
Metathesis Polymerization Catalyzed by a Ruthenium Carbene
Complex. Macromolecules 1995, 28, 4707−4713.
(38) Larroche, C.; Laval, J. P.; Lattes, A.; Basset, J. M. Ring-opening
polymerization of norbornene substituted with amine and ammonium
groups. J. Org. Chem. 1984, 49, 1886−1890.
(39) Wolfe, P. S.; Wagener, K. B. Investigation of Organoboronates
in Metathesis Polymerization. Macromolecules 1999, 32, 7961−7967.
(40) Wolf, W. J.; Lin, T.-P.; Grubbs, R. H. Examining the Effects of
Monomer and Catalyst Structure on the Mechanism of Ruthenium-
Catalyzed Ring-Opening Metathesis Polymerization. J. Am. Chem. Soc.
2019, 141, 17796−17808.
(41) Neises, B.; Steglich, W. Simple Method for the Esterification of
Carboxylic Acids. Angew. Chem., Int. Ed. 1978, 17, 522−524.
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